Phathom Pharmaceuticals
PHAT
47 hedge funds and large institutions have $566M invested in Phathom Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 14 increasing their positions, 12 reducing their positions, and 5 closing their positions.
140% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 5
18% more funds holding
Funds holding: 40 → 47 (+7)
17% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 12
13.14% less ownership
Funds ownership: 88.91% → 75.77% (-13%)
16% less capital invested
Capital invested by funds: $677M → $566M (-$111M)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$6.69M |
| 2 |
State Street
Boston,
Massachusetts
|
+$2.07M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$2.03M |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
+$627K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$563K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$3.65M |
| 2 |
Norges Bank
Oslo,
Norway
|
-$1.94M |
| 3 |
BlackRock
New York
|
-$1.86M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$890K |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$721K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Goldman Sachs
New York
| – | -$202K | -6,492 | Closed |
|
52
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$42K | -1,352 | Closed |
|
PHAT Hedge Fund Activity: Q1 2020 in Review
47 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Phathom Pharmaceuticals (PHAT) for Q1 2020, worth a combined $566M — down 16% from $677M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new PHAT positions and 5 closed out — a net gain of 7 holders — while 14 added to existing stakes and 12 trimmed.
The largest buyer was Janus Henderson Group, adding an estimated $6.69M. The largest seller was BVF Inc, cutting an estimated $3.65M.
- 47 institutional investors held Phathom Pharmaceuticals (PHAT) as of Q1 2020, up from 40 in Q4 2019.
- Funds reported $566M of Phathom Pharmaceuticals stock for Q1 2020, down 16% quarter-over-quarter.
- 12 funds opened new Phathom Pharmaceuticals positions in Q1 2020 and 5 closed out, a net change of +7 holders.
- The largest Phathom Pharmaceuticals buyer in Q1 2020 was Janus Henderson Group, an estimated $6.69M added.
- The largest Phathom Pharmaceuticals seller in Q1 2020 was BVF Inc, an estimated $3.65M sold.
Based on aggregated 13F filings for Q1 2020.